China Pharma Holdings (CPHI) Return on Sales (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Return on Sales came in at 0.01% in Q1 2026, little changed YoY from 0.01% in Q1 2025, and down 16.6% on a QoQ basis from 0.01% in Q4 2025.
China Pharma Holdings (CPHI) Return on Sales (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Return on Sales data on file, last reported at 0.01% in Q1 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
- Return on Sales fell to 0.01% in Q1 2026, from 0.01% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.0% in Q1 2023 to a low of 0.02% in Q2 2024.
- A 5-year average of 0.01% and a median of 0.01% in 2022 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2024 — Return on Sales slipped 1 bps — and 2025, when it gained 1 bps.
- Tracing CPHI's Return on Sales over 5 years: stood at 0.0% in 2022, then tumbled by 32 bps to 0.01% in 2023, then sank by 88 bps to 0.01% in 2024, then climbed by 8 bps to 0.01% in 2025, then decreased by 17 bps to 0.01% in 2026.
- The last three Return on Sales figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.35 Mn | 42.04 Mn | 83,566.00 | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |